These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 13129436)

  • 21. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.
    Gustavsen KM; Bradley MH; Wright AL
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S11-5. PubMed ID: 19843393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health economic analyses of the Global Programme to Eliminate Lymphatic Filariasis.
    Turner HC
    Int Health; 2020 Dec; 13(Suppl 1):S71-S74. PubMed ID: 33349885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa.
    Silumbwe A; Zulu JM; Halwindi H; Jacobs C; Zgambo J; Dambe R; Chola M; Chongwe G; Michelo C
    BMC Public Health; 2017 May; 17(1):484. PubMed ID: 28532397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mathematical models for lymphatic filariasis transmission and control: Challenges and prospects.
    Swaminathan S; Subash PP; Rengachari R; Kaliannagounder K; Pradeep DK
    Parasit Vectors; 2008 Feb; 1(1):2. PubMed ID: 18275593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial: Global elimination of lymphatic filariasis: fact or fantasy?
    Gyapong JO; Twum-Danso NA
    Trop Med Int Health; 2006 Feb; 11(2):125-8. PubMed ID: 16451335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass drug administration to eliminate lymphatic filariasis in India.
    Ramaiah KD; Das PK
    Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health Related Quality of Life, an appropriate indicator to assess the impact of morbidity management and disability prevention activities towards elimination of lymphatic filariasis.
    Kumari AK; Krishnamoorthy K; Harichandrakumar K; Das L
    Filaria J; 2007 Aug; 6():8. PubMed ID: 17723155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies and tools for the control/elimination of lymphatic filariasis.
    Ottesen EA; Duke BO; Karam M; Behbehani K
    Bull World Health Organ; 1997; 75(6):491-503. PubMed ID: 9509621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphatic filariasis in kenya since 1910, and the prospects for its elimination: a review.
    Wamae CN; Mwandawiro C; Wambayi E; Njenga S; Kiliku F
    East Afr Med J; 2001 Nov; 78(11):595-603. PubMed ID: 12219966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
    Hooper PJ; Bradley MH; Biswas G; Ottesen EA
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphatic filariasis: Treatment, control and elimination.
    Ottesen EA
    Adv Parasitol; 2006; 61():395-441. PubMed ID: 16735170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Mectizan Donation Program (MDP).
    Thylefors B
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continental-scale, data-driven predictive assessment of eliminating the vector-borne disease, lymphatic filariasis, in sub-Saharan Africa by 2020.
    Michael E; Singh BK; Mayala BK; Smith ME; Hampton S; Nabrzyski J
    BMC Med; 2017 Sep; 15(1):176. PubMed ID: 28950862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Introduction of the Filariasis Test Strip: A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis.
    Pantelias A; King JD; Lammie P; Weil GJ
    Am J Trop Med Hyg; 2022 May; 106(5_Suppl):56-60. PubMed ID: 35292584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eliminating lymphatic filariasis: a view from the field.
    Streit T; Lafontant JG
    Ann N Y Acad Sci; 2008; 1136():53-63. PubMed ID: 18579875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature.
    Wynd S; Melrose WD; Durrheim DN; Carron J; Gyapong M
    Bull World Health Organ; 2007 Jun; 85(6):493-8. PubMed ID: 17639248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining the cost of the Egyptian lymphatic filariasis elimination programme.
    Ramzy RM; Goldman AS; Kamal HA
    Filaria J; 2005 Aug; 4():7. PubMed ID: 16076397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Qualitative analysis of the impact of a lymphatic filariasis elimination programme using mass drug administration on Misima Island, Papua New Guinea.
    Wynd S; Carron J; Selve B; Leggat PA; Melrose W; Durrheim DN
    Filaria J; 2007 Jan; 6():1. PubMed ID: 17196113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elimination of neglected tropical diseases in the South-East Asia Region of the World Health Organization.
    Narain JP; Dash AP; Parnell B; Bhattacharya SK; Barua S; Bhatia R; Savioli L
    Bull World Health Organ; 2010 Mar; 88(3):206-10. PubMed ID: 20428388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing the first national database and map of lymphatic filariasis clinical cases in Bangladesh: Another step closer to the elimination goals.
    Karim MJ; Haq R; Mableson HE; Sultan Mahmood ASM; Rahman M; Chowdhury SM; Rahman AKMF; Hafiz I; Betts H; Mackenzie C; Taylor MJ; Kelly-Hope LA
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007542. PubMed ID: 31306409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.